GWS
TXG icon

Glassman Wealth Services’s 10x Genomics TXG Stock Holding History

Glassman Wealth Services’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32
Closed -$1.79K – 1701
2023
Q4 		$1.79K Hold
32
– – ﹤0.01% 1381
2023
Q3 		$1.32K Sell
32
-4
-11% -$208 ﹤0.01% 1465
2023
Q2 		$2.01K Hold
36
– – ﹤0.01% 1242
2023
Q1 		$2.01K Hold
36
– – ﹤0.01% 1241
2022
Q4 		$1.31K Buy
36
+29
+414% +$948 ﹤0.01% 1358
2022
Q3 		$0 Sell
7
-30
-81% -$1.14K ﹤0.01% 1993
2022
Q2 		$2K Buy
37
+6
+19% +$311 ﹤0.01% 1297
2022
Q1 		$2K Buy
31
+8
+35% +$700 ﹤0.01% 1273
2021
Q4 		$3K Buy
23
+4
+21% +$613 ﹤0.01% 1141
2021
Q3 		$3K Buy
19
+2
+12% +$343 ﹤0.01% 1103
2021
Q2 		$3K Buy
17
+3
+21% +$543 ﹤0.01% 1084
2021
Q1 		$3K Hold
14
– – ﹤0.01% 1026
2020
Q4 		$2K Hold
14
– – ﹤0.01% 1107
2020
Q3 		$2K Buy
+14
New +$1.47K ﹤0.01% 1042

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Glassman Wealth Services's TXG Position: Q1 2024 in Review

Glassman Wealth Services sold out of 10x Genomics (TXG) in Q1 2024, closing a stake of 32 shares — an estimated $1.79K sold.

Glassman Wealth Services first reported a position in TXG in Q3 2020 and held it in 14 quarters. The position peaked at $3K in Q4 2021. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.

  • Glassman Wealth Services reported no remaining 10x Genomics position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 32 10x Genomics shares in Q1 2024, an estimated $1.79K.
  • Glassman Wealth Services first reported a position in 10x Genomics in Q3 2020 and held it in 14 quarters.
  • Glassman Wealth Services's 10x Genomics position peaked at $3K in Q4 2021.
  • 290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.